D. Boral Capital Reaffirms Buy Rating for FibroBiologics (NASDAQ:FBLG)
D. Boral Capital restated their buy rating on shares of FibroBiologics (NASDAQ:FBLG – Free Report) in a research report released on Thursday,Benzinga reports. D. Boral Capital currently has a $16.00 price target on the stock. A number of other research firms also recently issued reports on FBLG. HC Wainwright reissued a “buy” rating and issued […]
D. Boral Capital restated their buy rating on shares of FibroBiologics (NASDAQ:FBLG – Free Report) in a research report released on Thursday,Benzinga reports. D. Boral Capital currently has a $16.00 price target on the stock. A number of other research firms also recently issued reports on FBLG. HC Wainwright reissued a “buy” rating and issued […]
